ALEC
Alector, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.95
+5.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 27.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -21.84x
- Price / sales
- 15.71x
- Price / cash flow
- -1.38x
Enterprise value
- Enterprise value
- $77.7M
- EV / sales
- 5.60x
- EV / EBITDA
- -0.70x
- EV / EBIT
- -0.61x
- Market cap
- $217.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026